These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20369743)

  • 1. [Difficulties in determining of the equivalent doses of inhaled glucocorticoids].
    Grzanka A; Jarzab J
    Pol Merkur Lekarski; 2010 Feb; 28(164):134-7. PubMed ID: 20369743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids.
    Hübner M; Hochhaus G; Derendorf H
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):469-88. PubMed ID: 16054538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit versus risk for oral, inhaled, and nasal glucocorticosteroids.
    Mortimer KJ; Tattersfield AE
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):523-39. PubMed ID: 16054541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing inhaled corticosteroids.
    Colice GL
    Respir Care; 2000 Jul; 45(7):846-53. PubMed ID: 10926382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
    Gulliver T; Eid N
    Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety.
    Derendorf H
    Respir Med; 1997 Nov; 91 Suppl A():22-8. PubMed ID: 9474364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective.
    Rohatagi S; Appajosyula S; Derendorf H; Szefler S; Nave R; Zech K; Banerji D
    J Clin Pharmacol; 2004 Jan; 44(1):37-47. PubMed ID: 14681340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primum non nocere...inhaled glucocorticosteroids in 2003].
    Lacronique J
    Rev Pneumol Clin; 2003 Jun; 59(3):129-37. PubMed ID: 13130199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of inhaled glucocorticoids.
    Padden J; Skoner D; Hochhaus G
    J Asthma; 2008; 45 Suppl 1():13-24. PubMed ID: 19093281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful withdrawal of inhaled corticosteroids in childhood asthma.
    Perera BJ
    Respirology; 2005 Jun; 10(3):385-8. PubMed ID: 15955154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems.
    Tayab ZR; Hochhaus G
    Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhaled glucocorticosteroids in treatment of bronchial asthma].
    Piotrowska B; Droszcz W
    Pol Merkur Lekarski; 1997 Feb; 2(8):126-8. PubMed ID: 9538658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhaled corticotherapy in asthma: when should it be started and how to stop?].
    Aubier M
    Rev Pneumol Clin; 1996; 52(2):145-9. PubMed ID: 8761645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of topical corticosteroids in the treatment of childhood asthma.
    Kerrebijn KF
    Am Rev Respir Dis; 1990 Feb; 141(2 Pt 2):S77-81. PubMed ID: 2178517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of action and mode of administration of high-dose inhaled corticotherapy in the treatment of asthma].
    Tenabene A; Dietemann-Molard A; Kapps M; Pauli G
    Rev Pneumol Clin; 1988; 44(6):273-7. PubMed ID: 3072652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral and inhaled corticoid therapy. Rivals or partners?].
    Lacronique J
    Rev Mal Respir; 1992; 9 Suppl 1():R69-71. PubMed ID: 1589633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual increase in body mass index in children with asthma on higher doses of inhaled steroids.
    Jani M; Ogston S; Mukhopadhyay S
    J Pediatr; 2005 Oct; 147(4):549-51. PubMed ID: 16227047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids: potency, dose equivalence and therapeutic index.
    Daley-Yates PT
    Br J Clin Pharmacol; 2015 Sep; 80(3):372-80. PubMed ID: 25808113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.